David Surprenant
Papers
1
Total Citations
3
H-Index
1
About
David Surprenant is a urologic researcher whose work centers on optimizing surgical outcomes in kidney cancer treatment, particularly through nephron-sparing techniques. His most notable contribution, the 2014 study "MP40-12 ENUCLEO-RESECTION MAXIMALLY PRESERVES RENAL PARENCHYMAL VOLUME IN PARTIAL NEPHRECTOMY," demonstrates a critical advance in partial nephrectomy methodology. By comparing enucleo-resection to standard partial nephrectomy, Surprenant and his team established that this technique significantly maximizes the preservation of healthy renal parenchyma—a vital consideration for patients with compromised kidney function or those requiring multiple surgeries. This work, published in the *Journal of Urology* and cited 3 times, has informed urologic surgeons seeking to balance oncologic control with functional preservation. Surprenant’s research addresses a core challenge in urologic oncology: how to remove tumors aggressively while sparing as much healthy tissue as possible. His findings contribute to the growing body of evidence supporting minimally invasive, parenchyma-sparing approaches, ultimately helping patients maintain better long-term renal function after cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1